Topic: 340B drug discount program
Hospitals are blasting CMS' proposal to survey certain hospitals on their 340B drug acquisition costs to better align payments.
CMS finalized a hospital payment rule that keeps cuts to 340B drug discount program and site-neutral payments.
Outpatient specialty drugs can be a lucrative income source for not-for-profit hospitals, but Washington presents some risks, Moody's says.
A 340B advocacy group is imploring Congress to not touch the drug discount program in Nancy Pelosi's drug legislation.
Hospital groups complained of CMS' decision to include 340B and site neutral payment cuts in a payment rule despite court rulings.
Physician groups slammed a court ruling that overturns CMS' site-neutral payments rule for clinic visits.
CMS wants every hospital to publish prices they negotiate with payers starting next year.